Although awareness of breast cancer (BRC) and the variety of available treatment options have significantly improved over the past two decades, both its incidence and mortality rates continue to rise considerably.Triple Negative Breast Cancer (TNBC) does not express ER, PR, or HER2, thus hormone treatment is not an effective method to target the same. The gene discussed is ERBB2; the disease is breast carcinoma.